Enfusion, Inc. Annual Operating Income (Loss) in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Enfusion, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to 2023.
  • Enfusion, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was $2.98M, a 10.9% increase year-over-year.
  • Enfusion, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was $6.71M, a 40.1% decline year-over-year.
  • Enfusion, Inc. annual Operating Income (Loss) for 2023 was $11.9M.
  • Enfusion, Inc. annual Operating Income (Loss) for 2022 was -$12M, a 95.7% increase from 2021.
  • Enfusion, Inc. annual Operating Income (Loss) for 2021 was -$276M, a 4642% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $11.9M +$23.9M Jan 1, 2023 Dec 31, 2023 10-K 2024-03-12
2022 -$12M +$264M +95.7% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-12
2021 -$276M -$282M -4642% Jan 1, 2021 Dec 31, 2021 10-K 2024-03-12
2020 $6.07M -$7.8M -56.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-10
2019 $13.9M Jan 1, 2019 Dec 31, 2019 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.